Mar 8, 2024
by: Lynda Charters The authors suggested genetic mutation may relax the body’s defenses and allow harmful bacteria to reach the eye. An experimental murine study found that “sight loss in…
Mar 8, 2024
Brassica Pharma has initiated a voluntary recall of its eye ointment products after an FDA inspection of a Brassica facility found a “lack of sterility assurance.” “For those patients who…
Feb 20, 2024
February is Low Vision Month There are a few ways to define low vision. I think of it as having vision that is not good enough to perform activities…
Feb 14, 2024
Happy Valentines Day Show your eyes some love- schedule your eye exam today.
Feb 12, 2024
Reviewed by Jeffry Gerson, OD, FAAO Macular degeneration is the leading cause of vision loss. This disease affects approximately 20 million people in the United States, and nearly 1.5 million…
Feb 6, 2024
by, David Hutton, Managing Editor, Ophthalmology Times In a news release, the FDA noted these are copycat eye drop products that consumers can easily mistake for Bausch +…
Jan 26, 2024
by: Jeffry Gerson, OD, FAAO Medical Director for the Macular Degeneration Association …
Jan 22, 2024
Two Compelling Cases of Significant IOP Reduction in Advanced Glaucoma Recent breakthroughs in minimally invasive glaucoma treatment are reshaping the approach to managing this disease. One standout innovation, the iStent…
Jan 22, 2024
David Eichenbaum, MD, discussed the status of the technology at the Retina 2024 meeting in Maui. Ocular gene therapy is not yet ready for prime time, according to David Eichenbaum,…
Jan 18, 2024
By: You Loong Yeong, OD Our eyes undergo natural changes as we age, and the risk of certain eye diseases increases. This infographic provides a…
Jan 18, 2024
Published January 12, 2024 | Originally published on MedicalXpress Breaking News-and-Events The Organoid group at the Hubrecht Institute produced the first organoid model of the human conjunctiva. These organoids mimic the function of the…
Jan 17, 2024
By Julie Poteet, OD, MS, CNS, FOWNS According to current statistics, one in every 10 people will have Alzheimer’s dementia by the time they are 65 years old. That risk will…
Jan 2, 2024
Published on: January 2, 2024 Gene Bruno, MS, MHS, RH(AHG) A look at lutein, zeaxanthin, astaxanthin, β-cryptoxanthin, capsanthin, and palmitoleic acid. Eye health supplements are a category of significant interest. According…
Jan 2, 2024
by: KRISTEN FISCHER Older adults who have cataract, age-related macular degeneration (AMD) or glaucoma are at a higher risk for falls and fractures, according to a new study. Glaucoma raises an individual’s…
Jan 2, 2024
By: Mark Gurarie Updated on January 2, 2024 Medically reviewed by: Christine L. Larsen, MD Age-related macular degeneration (AMD), often known as just macular degeneration, is a type of vision…
Dec 31, 2023
We are wishing everyone a Very Happy and Healthy New Year. The offices are currently closed and will reopen on Tuesday, January 2nd @ 8:00 am.
Dec 25, 2023
The Macular Degeneration Association would like to wish everyone a very Merry Christmas. Our offices will be closed Monday, December 25th through Monday, January 1st. We will reopen on Tuesday,…
Dec 18, 2023
Now on Android
Dec 18, 2023
Our eyes are crucially important in so many ways, but they are also incredibly complicated. By: Hayley Bennett Published: December 17, 2023 at 5:39 am Containing more than 100 million…
Nov 27, 2023
On Tuesday, November 28, 2022, from 12 am to 11:59 pm the MACULAR DEGENERATION ASSOCIATION is participating in the #GivingTuesday Campaign. Your donation will be maximized if you donate during this time…
Nov 23, 2023
Happy Thanksgiving to you and yours. “As we express our gratitude, we must never forget that the highest appreciation is not to utter words, but to live by them.”…
Nov 15, 2023
November 13 – 19 is Thyroid Eye Disease Awareness Week. What is thyroid eye disease (TED)? TED is an autoimmune disease in which the eye muscles and fatty tissue behind the…
Oct 20, 2023
Published October 19, 2023 | Originally published on MedicalXpress Breaking News-and-Events Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and…
Oct 17, 2023
Peter J. McDonnell, MD Neda Shamie, MD In this podcast episode, Ophthalmology Times’ co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of…
Oct 12, 2023
Research Opportunity for Wet Macular Degeneration Patients currently living in The United States. This is a 60-minute web-assisted phone interview via Zoom. Compensation is $120. Please sign up at the link below for more information…
Sep 13, 2023
Researchers find a link between sleep duration and the development of type 2 diabetes, despite other lifestyle factors A team of medical researchers with a diverse mix of backgrounds, all…
Sep 13, 2023
David Hutton, Managing Editor, Ophthalmology Times Bausch + Lomb Corp. announced the US commercial launch of perfluorohexyloctane ophthalmic solution (Miebo) for treatment of the signs and symptoms of dry eye disease…
Sep 11, 2023
Euin Cheong, OD Dual-purpose therapeutics help patients with both conditions.
Sep 11, 2023
Diabetics, rejoice: For some, an extra cup of coffee might be just what the doctor ordered By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz Published September 5, 2023 Key Takeaways Coffee has several bioactive…
Aug 21, 2023
August 18, 2023, EYLEA HD (AFLIBERCEPT) INJECTION 8 MG APPROVED BY FDA FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION (WAMD), DIABETIC MACULAR EDEMA (DME) AND DIABETIC RETINOPATHY (DR) Approval based…